Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-22T16:02:49.608Z Has data issue: false hasContentIssue false

Case of progressive facial hemiatrophy with cervical sympathetic hyperactivity as underlying aetiology

Published online by Cambridge University Press:  15 June 2012

H Monobe*
Affiliation:
Department of Otolaryngology, Hitachi General Hospital, Ibaraki, Japan Department of Otolaryngology, NTT Medical Center Tokyo, Tokyo, Japan
K Miyano
Affiliation:
Department of Otolaryngology, Showa General Hospital, Tokyo, Japan
R Kagoya
Affiliation:
Department of Otolaryngology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan
H Tojima
Affiliation:
Department of Otolaryngology, Hitachi General Hospital, Ibaraki, Japan
*
Address for correspondence: Dr Hiroko Monobe, Department of Otolaryngology, NTT Medical Center Tokyo, 5-9-22, Higashigotanda, Shinagawa, Tokyo, 141-8625, Japan Fax: +81 3 3448 6582 E-mail: [email protected]

Abstract

Objective:

We report a case of progressive facial hemiatrophy with cervical sympathetic hyperactivity as a possible underlying aetiology, based on clinical findings, three-dimensional computed tomography and thermographic imaging.

Methods:

We present a case report in which we describe the investigation and clinical course of progressive facial hemiatrophy, and we also review the world literature on this condition.

Results:

To our knowledge, this is the first report in the world literature of progressive facial hemiatrophy with cervical sympathetic hyperactivity indicated as a possible underlying aetiology, based on clinical findings, three-dimensional computed tomography and thermographic imaging.

Conclusion:

This syndrome may lead to atrophy of the subcutaneous adipose tissue with hyperfunction of the vegetative system. Although this is a rare syndrome, otolaryngologists should be aware of its symptoms, aetiology and treatment.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Singh, G, Bajpai, HS. Progressive facial hemiatrophy. Dermatologica 1969;138:288–91CrossRefGoogle ScholarPubMed
2Pensler, JM, Murphy, GF, Mulliken, JB. Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg 1990;85:669–76CrossRefGoogle ScholarPubMed
3Mazzeo, N, Fisher, JG, Mayer, MH, Mathieu, GP. Progressive hemifacial atrophy (Parry-Romberg syndrome). Case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:30–5CrossRefGoogle ScholarPubMed
4Abele, DC, Bedingfield, RB, Chandler, FW, Given, KS. Progressive facial hemiatrophy (Parry-Romberg syndrome) and borreliosis. J Am Acad Dermatol 1990;22:531–3CrossRefGoogle ScholarPubMed
5Moss, ML, Crikelair, GF. Progressive facial hemiatrophy following cervical sympathectomy in the rat. Arch Oral Biol 1960;1:254–8CrossRefGoogle ScholarPubMed
6Scope, A, Barzilai, A, Trau, H, Orenstein, A, Winkler, E, Haik, J. Parry-Romberg syndrome and sympathectomy – a coincidence? Cutis 2004;73:343–4, 346Google ScholarPubMed
7Carreno, M, Donaire, A, Barcelo, MI, Rumia, J, Falip, M, Agudo, R et al. Parry Romberg syndrome and linear scleroderma in coup de sabre mimicking Rasmussen encephalitis. Neurology 2007;68:1308–10CrossRefGoogle ScholarPubMed
8Sakuraoka, K, Tajima, S, Nishikawa, T. Progressive facial hemiatrophy: report of five cases and biochemical analysis of connective tissue. Dermatology 1992;185:196201CrossRefGoogle ScholarPubMed
9Moore, MH, Wong, KS, Proudman, TW, David, DJ. Progressive hemifacial atrophy (Romberg's disease): skeletal involvement and treatment. Br J Plast Surg 1993;46:3944CrossRefGoogle ScholarPubMed
10Guerrerosantos, J, Guerrerosantos, F, Orozco, J. Classification and treatment of facial tissue atrophy in Parry-Romberg disease. Aesthetic Plast Surg 2007;31:424–34CrossRefGoogle ScholarPubMed
11Rees, TD. Facial, atrophy. Clin Plast Surg 1976;3:637–46CrossRefGoogle Scholar
12Jablonska, S. Facial hemiatrophy and its relation to localized scleroderma. In: Jablonska, S, ed. Scleroderma and Pseudoscleroderma, 2nd edn.Warsaw: Polish Med, 1975;537–48Google Scholar
13Wartenberg, R. Progressive facial hemiatrophy. Arch Neurol Psychiatry 1945;54:7596CrossRefGoogle Scholar
14Togari, A, Arai, M. Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J Pharmacol Sci 2008;106:542–6CrossRefGoogle Scholar
15Kawano, Y, Araki, E, Arakawa, K, Matsumono, S, Yamada, T, Kira, J. A case of progressive hemifacial atrophy with Pourfourde Petit syndrome which was successfully treated by stellate ganglion block [in Japanese]. Rinsho Shinkeigaku 1999;39:731–4Google ScholarPubMed
16Aouba, A, Der Agopian, P, Genty-Le Goff, I, Mutschler, C, Janin, N, Patri, B. Pourfour du Petit syndrome: a rare aetiology of unilateral exophthalmos with mydriasis and lid retraction. Rev Med Interne 2003;24:261–5CrossRefGoogle ScholarPubMed
17Ségura, P, Speeg-Schatz, C, Wagner, JM, Kern, O. Claude Bernard-Horner syndrome and its opposite, Pourfour du Petit syndrome, in anesthesia and intensive care [in French]. Ann Fr Anesth Reanim 1998;17:709–24CrossRefGoogle ScholarPubMed
18Yokoyama, K, Sugiyama, K. Temporomandibular joint pain analgesia by linearly polarized near-infrared irradiation. Clin J Pain 2001;17:41–5CrossRefGoogle ScholarPubMed
19Wajima, Z, Shitara, T, Inoue, T, Ogawa, R. Linear polarized light irradiation around the stellate ganglion area increases skin temperature and blood flows [in Japanese]. Masui 1996;45:433–8Google Scholar